VEGFA and glioblastoma: Post-chemoradiation glioblastomas with a diffusion MRI phenotype that is known to predict a favorable response to anti-VEGF (ADCL ≥1240 μm2/s) have distinct biological features, with different perfusion and metabolic characteristics, and T2 relaxation times.